wydrukuj poleć znajomym zamów materiały
Od ilu lat pracuje Pani/Pan na różnych stanowiskach menedżerskich:

powyżej 20 lat
powyżej 15 lat
powyżej 10 lat
powyżej 5 lat
poniżej 5 lat
jeszcze nie byłam/-em menedżerem
nie chcę być menedżerem


Subskrypcja najnowszych ofert pracy





Nasi partnerzy:

rp.pl
gazeta.pl
onet.pl
interia.pl
wp.pl

Siemens Healthcare unveils the world's first integrated whole-body molecular MR system available for clinical use 2011.01.23

A world's first in imaging - integrated whole-body molecular MR system available for clinical use testing. Siemens unveils Biograph mMR whole-body integrated MR and PET system capable of simultaneous data acquisition. First system already undergoing clinical use testing in Munich, Germany.

From left to right: Horst Seehofer, Minister President of Bavaria and Prof. Dr. Markus Schwaiger, Director of the Clinic for Nuclear Medicine at Klinikum rechts der Isar.
Courtesy of Siemens press picture
 

Erlangen, Germany - November 19, 2010

Today, Siemens Healthcare unveils its new system, Biograph mMR, the world's first integrated whole-body molecular MR with simultaneous data acquisition technology, currently undergoing clinical use testing.

Siemens Healthcare unveils its new system, Biograph molecular magnetic resonance (mMR), the world's first integrated whole-body molecular MR with simultaneous data acquisition technology, currently undergoing clinical use testing. This revolutionary system comprises a magnetic resonance (MR) scanner and an integrated PET (Positron Emission Tomography) detection system with an architecture that performs as one. In the new 3-tesla hybrid system, Siemens developers have succeeded for the first time in simultaneously capturing MR and PET data with a whole-body system. The first Biograph mMR system has been installed at the university hospital Klinikum rechts der Isar of the Munich Technical University, Germany.
Courtesy of Siemens press picture
 
This revolutionary system comprises a magnetic resonance (MR) scanner and an integrated PET (Positron Emission Tomography) detection system with an architecture that performs as one.
In the new 3-tesla hybrid system, Siemens developers have succeeded for the first time in simultaneously capturing MR and PET data with a whole-body system.

With Biograph mMR, Siemens brings the first molecular MR system for clinical research that integrates MR with compact, specialized PET detectors.
Courtesy of Siemens press picture
 
The Biograph mMR system
has been installed at the university hospital Klinikum rechts der Isar of the Munich Technical University, Germany.

Prof. Dr. Markus Schwaiger, director of the clinic for nuclear medicine at the university hospital Klinikum rechts der Isar of the Munich Technical University, Germany.
Courtesy of Siemens press picture
 
“Together with our partner Siemens we are entering a new dimension in diagnostic imaging today“, said Prof. Dr. Markus Schwaiger, director of the clinic for nuclear medicine at the university hospital.
“We’ve initiated clinical use testing of Biograph mMR in an effort to diagnose diseases at a very early stage; to see the progression of disease and to use that information to develop a therapy plan precisely focused on the respective patient. Furthermore, we plan to use the system for cancer follow-up in the long run, by reducing radiation exposure by the use of the system.“

This image shows a brain cancer.
Courtesy of Siemens press picture
 
With the simultaneous acquisition of MR and PET data, this system is designed to provide new opportunities for imaging.
While MR provides exquisite morphological and functional details in human tissue, PET goes further to investigate the human body at the level of cellular activity and metabolism.

The picture shows a bone marrow imaging in case of cancer.
Courtesy of Siemens press picture
 
The innovative system has the potential to be a particularly valuable tool for identifying neurological, oncological and cardiac conditions of disease and in supporting the planning of appropriate therapies.

The picture shows a lung imaging in case of cancer.
Courtesy of Siemens press picture
 
Since MRI does not emit ionizing radiation, Biograph mMR may provide an added benefit with lower-dose imaging.

The picture shows a pelvis imaging in case of cancer.
Courtesy of Siemens press picture
 
The Biograph mMR
also opens new opportunities for research, such as the development of new biomarkers or new therapeutic approaches.

Walter Maerzendorfer, CEO of the Business Unit Magnetic Resonance at Siemens Healthcare.
Courtesy of Siemens press picture
 
“Biograph mMR is the latest breakthrough innovation of Siemens in the field of diagnostic imaging. It will be a new instrument for driving personalized medicine forward”, said Walter Maerzendorfer, CEO of the Business Unit Magnetic Resonance at Siemens Healthcare.


Britta Fuenfstueck, CEO of the Business Unit Molecular Imaging at Siemens Healthcare.
Courtesy of Siemens press picture
 
“Biograph mMR is designed to simultaneously acquire morphology, function, and metabolism for the entire body”, added Britta Fuenfstueck, CEO of the Business Unit Molecular Imaging at Siemens Healthcare.

Courtesy of Siemens press picture
 
MR and PET
have become an established part of everyday healthcare routines and have proven themselves to be valuable clinical diagnostic tools.

The picture shows a liver imaging in case of cancer.
Courtesy of Siemens press picture
 
The integration of these two technologies into a single system capable of simultaneous acquisition brings the potential to revolutionize the diagnosis of many conditions.
Initial research suggests that with this system, Molecular MR can scan the entire body in as little as 30 minutes for the combined exams, compared to one hour or more for sequential MR and PET examinations.

Courtesy of Siemens press picture
 
Siemens
envisions a wide range of clinical applications for molecular MR including the early identification and staging of malignancies, therapy planning (including surgery planning) and therapy control.


A technical revolution


Until now, it was nearly impossible to integrate MR and PET technologies: the conventional PET detectors, which use photomultiplier tubes, could not be used in the strong magnetic field generated by an MR system.

Courtesy of Siemens press picture
 
Integration
was further limited by the lack of space inside the MR device.
For this reason, MR-PET imaging was the result of two separate scans (MR and PET) with a significant time lag.

With Biograph mMR, Siemens brings the first molecular MR system for clinical research that integrates MR with compact, specialized PET detectors.

Prof. Dr. Markus Schwaiger, director of the clinic for nuclear medicine at the university hospital.
„We’ve initiated clinical use testing of Biograph mMR in an effort to diagnose diseases at a very early stage; to see the progression of disease and to use that information to develop a therapy plan precisely focused on the respective patient. Furthermore, we plan to use the system for cancer follow-up in the long run, by reducing radiation exposure by the use of the system.”
Courtesy of Siemens press picture
 
The Biograph mMR
– incorporating Tim, the “Total imaging matrix” technology from Siemens may make it even quicker and easier for clinicians to perform the MR examination.

More information and press pictures can be found under:

http://www.siemens.com/press/healthcare/Biograph-mMR  


The Siemens Healthcare Sector


The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids.

 
 
Siemens
offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare.
By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective.

Siemens Healthcare employs some 48,000 employees worldwide and operates around the world.

In fiscal year 2010 (to September 30), the Sector posted revenue of 12.4 billion euros and profit of around 750 million euros.

For further information please visit:

http://www.siemens.com/healthcare  


Contact

Mrs. Bianca Braun
Healthcare Sector
Siemens AG
Henkestr. 127
91052 Erlangen
Germany
Tel: +49 (9131) 84-3278
bianca.braun@siemens.com  


SOURCE: Siemens Healthcare

http://www.siemens.com/press/en/pressrelease/?press=/en/pressrelease/2010/imaging_it/him201011005.htm  



Prof. Dr. Hermann Requardt

Member of the Managing Board of Siemens AG, Sector CEO Healthcare, Head of Corporate Technology

Prof. Dr. Hermann Requardt
Courtesy of Siemens press picture
 
Born on February 11, 1955 in Engern, Germany

Education

Secondary school (baccalaureate)
Studied physics at the Technical University of Darmstadt and University of Frankfurt (Dr. phil. nat., Dipl.-Phys.)

Professional History

1979
Frankfurt University. Academic Assistant

1982
Deutsche Forschungs- und Versuchsanstalt f. Luft- und Raumfahrt e.V., Institute for Aviation Medicine. Research Assistant

1984
Joined Siemens AG, Medical Engineering Group, Sectional Imaging Division, Development for Nuclear Spin Tomography Physics, Imaging Systems and Magnetic Resonance. Researcher

1989
Magnetic Resonance Division. Head of Development

1991
Magnetic Resonance Division. Head of Project Management

1992
Head of High-Field Systems Development

1993
Pilot Project for Development, Production and Marketing of Surface Coils. Project Head

1995
Head of the Magnetic Resonance Division

January 2001
Member of the Group Executive Management of the Medical Solutions Group

May 2006
Member of the Managing Board of Siemens AG

June 2006
Honorary Professorship at Johann Wolfgang Goethe University in Frankfurt, Germany (Physics)

October 2006
Member of the Managing Board of Siemens AG
Head of the Corporate Technology Department

December 2008
Additionally: CEO of the Healthcare Sector


SOURCE: Siemens Healthcare

http://www.siemens.com/about/en/management-structure.htm#requardt  


ASTROMAN magazine


wydrukuj ten artykuł
  strona: 1 z 1
polecamy artykuły
SAMSUNG. The Galaxy Note9 Unpacked 2018 Takes a Leap Toward a More Connected World
SAMSUNG. Nowy Galaxy Note9 - dla tych, którzy pragną mieć wszystko
LANXESS plans to sell remaining 50 percent stake in joint venture ARLANXEO to Saudi Aramco
"Pępowina" zaprojektowana w Warszawie poleci na Marsa. Mechanizm zaprojektowali i wykonali inżynierowie z SENER Polska
Cisco Announces Intent to Acquire Duo Security for USD2.35 billion
NVIDIA. Why GeForce Is the Graphics Platform of The International 2018
Pipistrel Alpha Electro aircraft. First flight of an electric aircraft in Finland
Bridgestone premieres leading-edge products and solutions offering ultimate efficiency, convenience and sustainability at IAA 2018
Harley-Davidson Accelerates Strategy to Build Next Generation of Riders Globally
China-Europe Railway Express (Zhengzhou): The Silk Rail Road Gets on Track
Volkswagen's all-electric I.D. R race car sets a new standard at the world's highest road race at the 2018 Pikes Peak International Hill Climb
The Microsoft Inspire 2018: Opening doors for partner innovation, growth and differentiation
Intercept Sets Distance Record for Lockheed Martin's Hit-to-Kill Patriot Advanced Capability PAC-3 MSE
ESA: New satellite launch extends Galileo's global reach
Atos to acquire American company Syntel to create global digital transformation leader for USD3.4 billion
strona główna  |  oferty pracy  |  executive search  |  ochrona prywatności  |  warunki używania  |  kontakt     RSS feed subskrypcja RSS
Copyright ASTROMAN © 1995-2018. Wszelkie prawa zastrzeżone.
Projekt i wykonanie: TAU CETI.